Association of p53 immunoreactivity with high Gleason tumor grade in prostatic adenocarcinoma
Authors:
- Timothy A. JenningsTJTimothy A. Jennings
- 1 January 1994
- journal article
- Published by Elsevier in Human Pathology
- Vol. 25 (1) , 92-97
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 AccumulationJNCI: Journal of the National Cancer Institute, 1992
- Comparative analysis ofp53 protein immunoreactivity in prostatic, lung and breast carcinomasVirchows Archiv, 1992
- Markers of the metastatic phenotype in prostate cancerHuman Pathology, 1992
- p53, c-erbB-2 and the Epidermal Growth Factor Receptor in the Benign and Malignant ProstateJournal of Urology, 1992
- p53 Mutations in Human CancersScience, 1991
- Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genesJournal of Surgical Oncology, 1991
- Increased expression of mutant forms of p53 oncogene in primary lung cancerThe Lancet, 1990
- Localization of gene for human p53 tumour antigen to band 17p13Nature, 1986
- p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors.Molecular and Cellular Biology, 1985
- Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical StagingJournal of Urology, 1974